NHT
CRL icon

New Hampshire Trust’s Charles River Laboratories CRL Stock Holding History

New Hampshire Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-572
Closed -$115K – 205
2023
Q1 		$115K Buy
572
+54
+10% +$12.2K 0.03% 207
2022
Q4 		$113K Buy
+518
New +$113K 0.03% 204

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

New Hampshire Trust's CRL Position: Q2 2023 in Review

New Hampshire Trust sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 572 shares — an estimated $115K sold.

New Hampshire Trust first reported a position in CRL in Q4 2022 and held it in 2 quarters. The position peaked at $115K in Q1 2023. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • New Hampshire Trust reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • New Hampshire Trust sold 572 Charles River Laboratories shares in Q2 2023, an estimated $115K.
  • New Hampshire Trust first reported a position in Charles River Laboratories in Q4 2022 and held it in 2 quarters.
  • New Hampshire Trust's Charles River Laboratories position peaked at $115K in Q1 2023.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.